PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26463323-8	2015	The results of transwell migration assay showed that in the presence of HGF, afatinib plus bufalin combination therapy markedly decreased the number of invaded H1975 cells through the Matrigel chamber (48.98 +- 11.43), significantly lower than the 118.92 +- 37.29 of afatinib-treated or the 88.84 +- 19.53 of bufalin-treated cells (P < 0.05 for all).	bufalin	91-98	hepatocyte growth factor	Homo sapiens	72-75	
26463323-0	2015	[Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].	bufalin	1-8	hepatocyte growth factor	Homo sapiens	18-42	
26463323-1	2015	OBJECTIVE: To investigate the effects of bufalin in reversing hepatocyte growth factor (HGF)-induced resistance to afatinib in H1975 lung cancer cells, and explore its possible mechanism.	bufalin	41-48	hepatocyte growth factor	Homo sapiens	62-86	
26463323-1	2015	OBJECTIVE: To investigate the effects of bufalin in reversing hepatocyte growth factor (HGF)-induced resistance to afatinib in H1975 lung cancer cells, and explore its possible mechanism.	bufalin	41-48	hepatocyte growth factor	Homo sapiens	88-91	
26463323-8	2015	The results of transwell migration assay showed that in the presence of HGF, afatinib plus bufalin combination therapy markedly decreased the number of invaded H1975 cells through the Matrigel chamber (48.98 +- 11.43), significantly lower than the 118.92 +- 37.29 of afatinib-treated or the 88.84 +- 19.53 of bufalin-treated cells (P < 0.05 for all).	bufalin	309-316	hepatocyte growth factor	Homo sapiens	72-75	
23533466-0	2013	Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis.	bufalin	0-7	hepatocyte growth factor	Homo sapiens	17-20	
23533466-6	2013	Our studies showed that bufalin could reverse resistance to reversible and irreversible EGFR-TKIs induced by exogenous HGF in EGFR mutant lung cancer cells by inhibiting the Met/PI3K/Akt pathway and inducing death signaling.	bufalin	24-31	hepatocyte growth factor	Homo sapiens	119-122	
23533466-5	2013	The purpose of this study was to determine whether bufalin, a major bioactive component of Venenum Bufonis, could reverse HGF-induced resistance to reversible and irreversible EGFR-TKIs in mutant lung cancer cells PC-9, HCC827, and H1975.	bufalin	51-58	hepatocyte growth factor	Homo sapiens	122-125